• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMVIE US CORP LLC IMPL TAPERED SCR-V SBM 6M M 5.7MM 10MM; DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMVIE US CORP LLC IMPL TAPERED SCR-V SBM 6M M 5.7MM 10MM; DENTAL IMPLANT Back to Search Results
Catalog Number TSV6B10
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Unspecified Infection (1930); Inflammation (1932); Osteolysis (2377)
Date of Event 03/03/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Zimvie complaint number (b)(4).D6a: device implant date: asku.D6b: device explant date: asku.G4: additional pma/510(k) number ¿ k011028|k013227.A summary investigation has been completed for peri-implantitis events recognizing that a definitive root cause cannot be identified due to a wide range of external factors (non-design or manufacturing related), including medical conditions (e.G., diabetes, poor bone quality, etc.) / patient habits (e.G., smoking) and surgical technique.Previously completed investigations for these events have not identified any signals indicating potential non-conformances affecting the manufacturing and sterilization processes.Furthermore, the probability of a manufacturing or design defect that might lead to peri-implantitis occurring and escaping the available detections has been assessed and found remote and almost nonexistent.Should additional information be received which indicates that the device may have caused or contributed to the event, an additional report will be submitted.
 
Event or Problem Description
It was reported that the patient noticed that the implant at tooth site # 30 was removed because of mobility due to bone loss and inflammation associated with peri-implantitis.
 
Additional Manufacturer Narrative
This report is being submitted to relay additional information.Correction: d4 unique device identifier # was submitted incorrectly as (b)(4).Upon review, the correct unique device identifier # should be (b)(4).Additionally, the d6a and d6b device implant date and device explant date were originally submitted without dates.Upon review, the correct device implant date is (b)(6) 2017, and the correct device explant date is (b)(6) 2025.The following sections are being reported: b4: date of this report was updated.D4: device unique identifier # was updated.D6a: device implant date was updated.D6b: device explant date was updated.G1: manufacturer contact email address was updated.G3: date received by manufacturer was updated.G6: type of report was updated.H2: type of follow up was updated.H3: device evaluated by manufacturer was updated.H6: type of investigation code was added: 4109, 4111, 3331 and 4110.H6: investigation findings code was added: 213.H6: investigation conclusions code was added: 4310 and 4315.H10: narrative/data was updated.Dhr review was completed for the subject lot number.No deviations or non-conformances, which could have caused or contributed to the reported event, were noted as part of the dhr.Sterilization record was reviewed and verified to have passed all sterilization activities with no issues or nonconformities identified.Complaint history review was performed for the reported lot number for similar events and one other complaint was identified.As documented in the summary investigations, contributing factors for the reported event likely exist outside of zimvie control, including those related to patient biological factors/condition and surgical technique.Based on the summary investigations, no malfunction occurred upon investigation.The reported events remain non-verifiable as they are a medical condition.Monthly trending to date has not identified any statistical triggers suggesting potential design or manufacturing related issues.Previously completed investigations for infection, bone loss, and/or peri-implantitis problems reported in association with implant failure have not identified any signals indicating potential non-conformances impacting the manufacturing and sterilization processes.Therefore, escalation to capa is not required.
 
Event or Problem Description
No additional event information received at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPL TAPERED SCR-V SBM 6M M 5.7MM 10MM
Common Device Name
DENTAL IMPLANT
Manufacturer (Section D)
ZIMVIE US CORP LLC
4555 riverside drive
palm beach gardens FL 33410
Manufacturer (Section G)
ZIMVIE US CORP LLC
4555 riverside drive
palm beach gardens FL 33410
Manufacturer Contact
carlos  gordian-arroyo
4555 riverside drive
palm beach gardens, FL 33410
5619713230
MDR Report Key23464508
Report Number0001038806-2025-02913
Device Sequence Number13337209
Product Code DZE
UDI-Device Identifier00889024019379
UDI-Public(01)00889024019379(17)210228(10)63290538
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
K061410
Exemption Number5645646
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Expiration Date02/28/2021
Device Catalogue NumberTSV6B10
Device Lot Number63290538
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer10/15/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date11/04/2025
Supplement Report FDA Received Date12/09/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/25/2016
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age67 YR
Patient SexFemale
Patient EthnicityNon Hispanic
-
-